Novartis AG
Process and intermediates
Last updated:
Abstract:
The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.
Status:
Grant
Type:
Utility
Filling date:
25 Jun 2019
Issue date:
6 Sep 2022